aspartic acid has been researched along with ecallantide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, DE; Davie, RL; Edwards, HJ; Evans, DM; Hampton, SL; Hodgson, ST; McEwan, PA; Pethen, SJ; Roe, MB; Rushbrooke, LJ; Smith, AJ; Stocks, MJ | 1 |
1 other study(ies) available for aspartic acid and ecallantide
| Article | Year |
|---|---|
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema.
Topics: Administration, Oral; Angioedemas, Hereditary; Antiviral Agents; Aspartic Acid; Bradykinin; Humans; Plasma Kallikrein | 2022 |